Internal neuromodulation devices directly act upon nerves. It is the technology known for alteration of nerve activity directly to a target area by sending electrical or pharmaceutical agents directly to a target area. The neuromodulation devices can treat nearly every disease considering every area of body. The diseases or symptoms from headache to spinal cord damage to tremor and many others. Neuromodulation technology is significantly improving in biotechnology with its broad therapeutic scope. More specifically, it is employed to treat unmanageable chronic pain or movement conditions. According to the study on neuromodulation devices and therapies has shown that neuromodulation is a safe, effective, and long-term treatment for chronic pain and movement disorders. Patients with the diseases such as Parkinson’s disease, essential tremor, primary dystonia, chronic back and leg pain associated with peripheral vascular disease (PVD), complex regional pain syndrome (CRPS), and failed back surgery syndrome (FBSS) can benefit from neuromodulation therapy. As the hardware becomes smaller and easy to use the implantable devices used for neuromodulation have taken a dive headlong with the introduction of smaller devices, and rechargeable systems. These systems are considered with larger but useable complexity which denotes towards the growth of neuromodulation devices segment.
The internal neuromodulation devices market can be segmented into product type, application, end-user, and geography. In terms of product type, the market can be segmented into deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, spinal cord stimulators, and other internal neuromodulation devices. The spinal cord segment of the internal neuromodulation devices market is anticipated to expand rapidly during the forecast period. The product type segment is estimated to expand significantly in the near future due to its high usage in the treatment of chronic pain. Rising gastric and chronic and nerve disability conditions are driving the expansion of the market globally. The market is anticipated to expand due to growing safety awareness and efficacy of the neuromodulation devices, increasing neurological disorders prevalence and increasing number of clinical trials, globally, for the progress of innovative technologies. Stringent approval policies and low number of trained healthcare professionals are restraining the expansion of the market.
In terms of application, the market can be segmented into failed back syndrome, tremors, epilepsy, chronic pain management, Parkinson’s disease, depression, urinary and fecal incontinence, gastroparesis, migraine, obsessive-compulsive disorder, and others. The chronic pain management segment accounts for a significant share in the application category of the internal neuromodulation devices market. Increasing prevalence of chronic conditions is a major factor driving the expansion of the segment. In terms of end-user, the internal neuromodulation devices market can be segmented into hospitals, clinics, and home healthcare. The hospitals segment is projected to hold prominent share in the end-user category of the internal neuromodulation devices market.
In terms of geography, the global internal neuromodulation devices market can be segmented into North America, Europe, Asia Pacific, and Rest of the world, North America held significant share of the internal neuromodulation devices market due to high healthcare awareness, prevalence of chronic disorders, and technological advancement in the region. Europe accounted for the second largest share of the internal neuromodulation devices market due to rising ageing population. However, Asia Pacific represent are estimated to expand rapidly in during the forecast period due to increasing awareness, gradual adoption of improved technologies, emerging health care infrastructures, increased purchasing power of hospitals, and rise in population. Followed by Latin America and Middle- East & Africa.
Key global players in the internal neuromodulation devices market are Medtronic plc, LivaNova PLC, Cyberonics, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, EnteroMedics Inc, BioControl Medical, Bioness Inc., Nevro Corporation, and NeuroPace Inc. Moreover, regional players along with global players are contributing for a significant share in the internal neuromodulation devices market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.